The 2023-2028 Outlook for Anti-Inflammatory Autoimmune Disease Therapeutics in Japan
This study does not report actual sales data (which are simply unavailable, in a comparable or consistent manner in virtually all cities in Japan). This study gives, however, Professor Parker's estimates for the latent demand, or potential industry earnings (P.I.E.), for anti-inflammatory autoimmune disease therapeutics in Japan. It also shows how the P.I.E. is divided and concentrated across the cities and regional markets of Japan. For each region, he also shows his estimates of how the P.I.E....
11/28/2022 | Japan Outlook 2023
The 2023-2028 Outlook for Anti-Inflammatory Asthma Drugs in Japan
This study does not report actual sales data (which are simply unavailable, in a comparable or consistent manner in virtually all cities in Japan). This study gives, however, Professor Parker's estimates for the latent demand, or potential industry earnings (P.I.E.), for anti-inflammatory asthma drugs in Japan. It also shows how the P.I.E. is divided and concentrated across the cities and regional markets of Japan. For each region, he also shows his estimates of how the P.I.E. grows over time. I...
11/28/2022 | Japan Outlook 2023
The 2023-2028 Outlook for Anti-Icing Coatings in Japan
This study does not report actual sales data (which are simply unavailable, in a comparable or consistent manner in virtually all cities in Japan). This study gives, however, Professor Parker's estimates for the latent demand, or potential industry earnings (P.I.E.), for anti-icing coatings in Japan. It also shows how the P.I.E. is divided and concentrated across the cities and regional markets of Japan. For each region, he also shows his estimates of how the P.I.E. grows over time. In order to ...
11/28/2022 | Japan Outlook 2023
The 2023-2028 Outlook for Anti-Idiopathic Pulmonary Fibrosis Drugs in Japan
This study does not report actual sales data (which are simply unavailable, in a comparable or consistent manner in virtually all cities in Japan). This study gives, however, Professor Parker's estimates for the latent demand, or potential industry earnings (P.I.E.), for anti-idiopathic pulmonary fibrosis drugs in Japan. It also shows how the P.I.E. is divided and concentrated across the cities and regional markets of Japan. For each region, he also shows his estimates of how the P.I.E. grows ov...
11/28/2022 | Japan Outlook 2023
The 2023-2028 Outlook for Antihypertensives in Japan
This study does not report actual sales data (which are simply unavailable, in a comparable or consistent manner in virtually all cities in Japan). This study gives, however, Professor Parker's estimates for the latent demand, or potential industry earnings (P.I.E.), for antihypertensives in Japan. It also shows how the P.I.E. is divided and concentrated across the cities and regional markets of Japan. For each region, he also shows his estimates of how the P.I.E. grows over time. In order to ma...
11/28/2022 | Japan Outlook 2023
The 2023-2028 Outlook for Antihypertensive Drugs in Japan
This study does not report actual sales data (which are simply unavailable, in a comparable or consistent manner in virtually all cities in Japan). This study gives, however, Professor Parker's estimates for the latent demand, or potential industry earnings (P.I.E.), for antihypertensive drugs in Japan. It also shows how the P.I.E. is divided and concentrated across the cities and regional markets of Japan. For each region, he also shows his estimates of how the P.I.E. grows over time. In order ...
11/28/2022 | Japan Outlook 2023
The 2023-2028 Outlook for Anti-Hypertensive Diuretic Drugs in Japan
This study does not report actual sales data (which are simply unavailable, in a comparable or consistent manner in virtually all cities in Japan). This study gives, however, Professor Parker's estimates for the latent demand, or potential industry earnings (P.I.E.), for anti-hypertensive diuretic drugs in Japan. It also shows how the P.I.E. is divided and concentrated across the cities and regional markets of Japan. For each region, he also shows his estimates of how the P.I.E. grows over time....
11/28/2022 | Japan Outlook 2023
The 2023-2028 Outlook for Antifungal Drugs in Japan
This study does not report actual sales data (which are simply unavailable, in a comparable or consistent manner in virtually all cities in Japan). This study gives, however, Professor Parker's estimates for the latent demand, or potential industry earnings (P.I.E.), for antifungal drugs in Japan. It also shows how the P.I.E. is divided and concentrated across the cities and regional markets of Japan. For each region, he also shows his estimates of how the P.I.E. grows over time. In order to mak...
11/28/2022 | Japan Outlook 2023
The 2023-2028 Outlook for Antifungal Azole Drugs in Japan
This study does not report actual sales data (which are simply unavailable, in a comparable or consistent manner in virtually all cities in Japan). This study gives, however, Professor Parker's estimates for the latent demand, or potential industry earnings (P.I.E.), for antifungal azole drugs in Japan. It also shows how the P.I.E. is divided and concentrated across the cities and regional markets of Japan. For each region, he also shows his estimates of how the P.I.E. grows over time. In order ...
11/28/2022 | Japan Outlook 2023
The 2023-2028 Outlook for Antifreeze in Japan
This study does not report actual sales data (which are simply unavailable, in a comparable or consistent manner in virtually all cities in Japan). This study gives, however, Professor Parker's estimates for the latent demand, or potential industry earnings (P.I.E.), for antifreeze in Japan. It also shows how the P.I.E. is divided and concentrated across the cities and regional markets of Japan. For each region, he also shows his estimates of how the P.I.E. grows over time. In order to make thes...
11/28/2022 | Japan Outlook 2023
